Earnings summaries and quarterly performance for METLIFE.
Executive leadership at METLIFE.
Michel A. Khalaf
President and Chief Executive Officer
Adrienne O'Neill
Executive Vice President and Chief Accounting Officer
Bill Pappas
Executive Vice President and Head of Global Technology and Operations
Eric Clurfain
Regional President, Latin America
John D. McCallion
Executive Vice President and Chief Financial Officer
Lyndon Oliver
Regional President, Asia
Marlene Debel
Executive Vice President and Chief Risk Officer
Michael Roberts
Executive Vice President and Chief Marketing Officer
Monica Curtis
Executive Vice President and Chief Legal Officer
Nuria Garcia
Regional President, EMEA
Ramy Tadros
Regional President, U.S. Business and Head of MetLife Holdings
Shurawl Sibblies
Executive Vice President and Chief Human Resources Officer
Board of directors at METLIFE.
Carla A. Harris
Director
Carlos M. Gutierrez
Director
Christian Mumenthaler
Director
Denise M. Morrison
Director
Diana L. McKenzie
Director
Jeh C. Johnson
Director
Laura J. Hay
Director
Mark A. Weinberger
Director
R. Glenn Hubbard
Chairman of the Board
William E. Kennard
Director
Research analysts who have asked questions during METLIFE earnings calls.
Ryan Krueger
KBW
7 questions for MET
Suneet Kamath
Jefferies
6 questions for MET
Wesley Carmichael
Autonomous Research
6 questions for MET
Joel Hurwitz
Dowling & Partners Securities, LLC
5 questions for MET
Thomas Gallagher
Evercore
5 questions for MET
Alex Scott
Barclays PLC
3 questions for MET
Elyse Greenspan
Wells Fargo
3 questions for MET
Jamminder Bhullar
JPMorgan Chase & Co.
3 questions for MET
Cave Montazeri
Deutsche Bank
2 questions for MET
Jimmy Bhullar
JPMorgan Chase & Co.
2 questions for MET
Tom Gallagher
Evercore ISI
2 questions for MET
Wilma Burdis
Raymond James Financial
2 questions for MET
Wilma Jackson Burdis
Raymond James
2 questions for MET
John Barnidge
Piper Sandler
1 question for MET
Nick Anido
Wells Fargo & Company
1 question for MET
Recent press releases and 8-K filings for MET.
- MetLife Investment Management closed its acquisition of PineBridge Investments on December 30, 2025, creating a combined asset management platform with $734.7 billion in pro forma assets under management as of September 30, 2025.
- Brian Funk, president of MetLife Investment Management, will lead the combined business, reflecting a new senior leadership team drawn from both organizations.
- More than half of the acquired assets are held by non-U.S. investors (one-third in Asia); the deal excludes PineBridge’s private equity funds group and its joint venture in China.
- On Dec. 30, 2025, MetLife Investment Management closed its acquisition of PineBridge Investments, adding roughly $100 billion of assets and creating a combined institutional asset manager with about $734.7 billion in pro forma AUM.
- The deal, valued at up to $1.2 billion with $800 million paid upfront, excludes PineBridge’s private equity funds group and China joint venture, and brings expanded alternatives capabilities in CLOs, direct lending and European real estate.
- The acquisition is central to MetLife’s “New Frontier” strategy to accelerate growth in asset management, diversify offerings and deepen its international footprint, notably across Asia and Europe.
- The transaction positions MIM among top-tier global asset managers and establishes a combined leadership team under president Brian Funk.
- MetLife Investment Management closed its acquisition of PineBridge Investments on December 30, 2025, creating a combined business that manages $734.7 billion in assets .
- The deal advances MetLife’s New Frontier strategy, merging MIM’s institutional scale with PineBridge’s global footprint and specialization .
- Post-close leadership is consolidated under President Brian Funk, reporting to CFO and Head of MIM John McCallion .
- More than 50% of the acquired assets are held outside the U.S. (one-third in Asia); the transaction excludes PineBridge’s private equity funds group and its China joint venture .
- Glenfarne acquired four Chilean energy projects totaling 909 MW of capacity, including 588 MW of solar and 1.61 GWh of battery storage, from METLEN.
- The transaction was valued at $865 million including assumed debt, supported by a $1 billion+ financing package underwritten by Scotiabank, BNP Paribas, and Société Générale.
- Assets are located in Chile’s northern provinces—known for high solar irradiance—and BESS components are slated for completion in H1 2026 to optimize utilization.
- The deal enhances Glenfarne’s technology, geographic, and revenue diversification, adding high-quality, stable EBITDA to its portfolio.
- Metlen sold a large segment of its Chilean renewables portfolio to GAC RS Chile II SpA for USD 865 million, up from an initial USD 815 million.
- The transaction covers four projects with 588 MW of solar PV capacity and 1,610 MWh of co-located BESS.
- The deal aligns with Metlen’s Global Asset Rotation Plan, boosting liquidity and strengthening its balance sheet.
- Metlen’s shares rose about 2.2%, trading at EUR 42.10 in London following the closing.
- MetLife completed a $10 billion variable annuity risk transfer transaction with Talcott Resolution Life Insurance Company, reducing portfolio risk and accelerating runoff of legacy U.S. retail blocks.
- The deal incurs expected foregone annual adjusted earnings of $100 million, partially offset by $45 million in annual hedge cost savings.
- MetLife Investment Management will oversee approximately $6 billion of assets under new investment management agreements with Talcott.
- This transaction exemplifies MetLife’s disciplined execution of risk transfer strategies within its closed-block businesses.
- Adjusted earnings of $1.6 billion, or $2.34 EPS, up ~21% YoY, driven by higher variable investment income and volume growth.
- Variable investment income of $483 million, exceeding guidance of $425 million, with private equity returns of 3% for the quarter.
- Segment results: Group Benefits $457 million (+6%), Retirement & Income Solutions $423 million (+15%), Asia $473 million (+36%), Latin America $222 million (+2%), EMEA $89 million (+19%).
- Capital return: $875 million to shareholders in Q3 (dividends $375 million; share repurchases $500 million), bringing YTD buybacks to ~$2.6 billion; secured $12 billion of pension risk transfer in Q4.
- Direct expense ratio improved to 11.6%, below the full-year target of 12.1%, supported by cost discipline and technology investments.
- MetLife reported Q3’25 net income of $818 M (EPS $1.22) and adjusted earnings of $1.584 B (EPS $2.37), or $1.566 B ex-notable items (EPS $2.34).
- Segment adjusted earnings ex-notable items: Group Benefits $457 M (+6% YoY), Asia $473 M (+36%), Retirement & Income Solutions $423 M (+15%), EMEA $89 M (+19%), MetLife Holdings $190 M (+12%).
- Holding company cash and liquid assets of $4.9 B at quarter-end; returned ~$875 M to shareholders in Q3 via $500 M buybacks and $375 M dividends; YTD buybacks of $2.6 B through October.
- U.S. Statutory Adjusted Capital of $17.1 B at 9/30/25 (flat QoQ); Japan Solvency Margin ratio 740%; estimated Economic Solvency Ratio of 170–190% for period ending March 2026.
- MetLife delivered $1,566 million of adjusted earnings ex. total notable items in Q3 2025, up 15% YoY, and $2.34 adjusted EPS, up 21% YoY.
- Broad-based segment growth: Group Benefits earned $457 million (+6%), Retirement & Income Solutions $423 million (+15%), and Asia $473 million (+36%) in Q3 2025.
- Strong balance sheet: total AUM of $633 billion, MetLife Investment Management on a path to $1 trillion AUM, and $4.7 billion capital returned in 2024.
- Continued financial discipline with 2-digit adjusted EPS growth target, 15–17% adjusted ROE goal (from 12–14%), and 100 bps direct expense ratio improvement target.
- MetLife delivered $1.6 billion in adjusted earnings, or $2.37 EPS (up 22% YoY; ex-notables EPS of $2.34, +21%), driven by strong investment margins and volume growth. Variable investment income was $483 million, above the $425 million outlook, supported by 3% private equity returns, yielding a 16.7% adjusted ROE ex-notables.
- Core segments posted robust growth: group benefits adjusted earnings of $457 million (+6%) with a 230 bps sequential improvement in non-medical health loss ratio; retirement & income solutions delivered $423 million (+15%) alongside the launch of Chariot Re with ~$10 billion of liabilities; Asia earnings rose 36% to $473 million on 34% constant-currency sales growth.
- Capital management remained disciplined: returned $875 million in Q3 (≈$375 million dividends; $500 million share buybacks), lifting year-to-date buybacks to ~$2.6 billion; holding-company liquidity of $4.9 billion exceeds the $3–4 billion target; on track to close the PineBridge acquisition and VA block sale in Q4.
- Strategic metrics and outlook: 2024 value of new business capital deployment of $3.4 billion earned a 19% IRR with a five-year payback; Q3 direct expense ratio was 11.6% versus 12.1% full-year target; beginning Q4, MetLife Investment Management will be reported as a standalone segment.
Quarterly earnings call transcripts for METLIFE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more